[Music] Hello and welcome to Market Domination. I'm Josh Lipton live from our NYC headquarters and markets are mixed here as hopes of averting a government shutdown are dwindling. Going to dig into that story further, but right now there's just an hour to go until the closing bell.Let's take a look at the major averages. The Dow is basically flat here. The S&P 500, your broad gauge, that is up about a tenth of a percent.You know, your tech heavy NASDAQ also roughly flat right now. Let's welcome in our Washi ...

And right now we are 2 minutes away from the end of the trading day. Romaine Bostick here with Katie Greifeld taking you through to that closing bell. It's a global simulcast.There's Carol Massar, Tim Stenovec in the radio booth. Welcome to our audiences across all of our Bloomberg platforms, including YouTube here on the final trading day of the month and the quarter. Right now, looking at an S&P 500 and a Dow and the Russell 2000 locking in a fifth straight month of gains.Yeah, pretty significant, right. ...

Americans enrolled in Medicaid will get "most-favored-nations" pricing, the president said, meaning the U.S. drug prices would match the lower prices of other developed countries. Pfizer will also sell drugs at a direct-to- consumer website that has been dubbed TrumpRx. The government is setting up the website, which will allow Americans to buy medications at prices the government negotiates. Pfizer shares remain in the red for 2025 despite Tuesday's pop. Â ANGELA WEISS / AFP via Getty Images Close KEY TAKE ...

Gains in pharmaceutical stocks lifted indexes, despite the threat of an imminent government shutdown. ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

Cadrenal Therapeutics (NasdaqCM:CVKD) 2025 Conference September 30, 2025 03:30 PM ET Company ParticipantsTerry Ferguson - Chief Medical OfficerModeratorAll right, hello everyone. Thank you so much for joining us throughout the day here at the Lytham Partners Fall 2025 Investor Conference. Again, my name is Robert Blum, Managing Partner here at Lytham Partners. Coming up next, we have a presentation from Cadrenal Therapeutics, company trades under the ticker symbol CVKD on the NASDAQ. Presenting from the com ...

I have covered Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) twice before, and on both occasions, my predictions of share price performance on the basis of fundamental analysis were proved correct over the following months. MyI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the ke ...

The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday. ...

In this article, we will look at the Top 12 Blue Chip Stocks to Buy At 52-Week Lows.On September 30, Elyse Ausenbaugh, Head of Investment Strategy at JPMorgan Wealth Management, joined CNBC for an interview to discuss the current market rally. She noted that there is a strong momentum going forward in 2025, which is likely to continue in 2026 as well. She sees improvements in the macroeconomic environment and anticipates powerful tailwinds from significant investments in AI.She highlighted that the current ...

Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.Trump made the announcement at the White House alongside Pfizer CEO Albert Bourla just hours ahead of a possible government shutdown in a partisan standoff over health care and spending.Pfizer Inc., one of the largest U.S. drugmakers, produces the COVID-19 vaccine Comirnaty ...